Why CRISPR Therapeutics Stock Is Stuck Despite Boasting the World’s First Approved CRISPR Therapy Life Science
S&P 500 Flashes Rare Bullish Signal: After 19% Two-Month Surge, History Says 28% Gain Next Consumer Goods, Financial Service, Life Science, Technology
Tech and Banking Giants Dominate Decade of U.S. Stock Buybacks, Led by Apple’s $755 Billion Spree Financial Service, Technology
Oil Prices Fall Meets Employment Resilience, Fed Policy Path Falls into “Hawk-Dove Debate” Financial Service
Intuitive Surgical Draws Big Citadel Bet as Ken Griffin Trims Nvidia, Amazon Stakes Life Science, Technology